Anti-CPSF30/NAR antibody [EPR7433] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal CPSF30/NAR antibody. Carrier free. Suitable for WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
CPSF30, NAR, NEB1, CPSF4, Cleavage and polyadenylation specificity factor subunit 4, Cleavage and polyadenylation specificity factor 30 kDa subunit, NS1 effector domain-binding protein 1, No arches homolog, CPSF 30 kDa subunit, Neb-1
- WB
Unknown
Western blot - Anti-CPSF30/NAR antibody [EPR7433] - BSA and Azide free (AB248378)
This data was developed using ab131218, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-CPSF30/NAR antibody [EPR7433] - BSA and Azide free (ab248378) at 1/1000 dilution
Lane 1:
Jurkat cell lysate at 10 µg
Lane 2:
293T cell lysate at 10 µg
Predicted band size: 30 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-CPSF30/NAR antibody [EPR7433] - BSA and Azide free (AB248378)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (1)
-
Anti-CPSF30/NAR antibody [EPR7433]
Reactivity data
Product details
ab248378 is the carrier-free version of ab131218.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CPSF30 helps in mRNA processing by forming part of the CPSF complex. This complex is important for cutting and adding a poly-A tail to the 3' end of pre-mRNAs a step essential for mRNA stability export and translation. CPSF30 interacts directly with other CPSF subunits such as CPSF73 and CPSF100 enabling the PCAS endonuclease activity required for cleaving pre-mRNA. This activity facilitates proper gene expression regulation in response to different cellular conditions.
Pathways
CPSF30 is an integral part of the post-transcriptional regulation of gene expression. The protein participates in both the mRNA polyadenylation pathway and mRNA surveillance pathway ensuring accurate mRNA maturation and degradation of faulty mRNA. Through these pathways CPSF30 interacts with related proteins such as FIP1 and CSTF77 which assist in the precise control of gene expression by assuring proper RNA transcript modification and functionality.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Oncology letters 24:457 PubMed36380881
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com